A freshly-amended 13D filing with the US SEC showed that Sam Isaly’s OrbiMed Advisors has sold some of its shares of Affimed N.V. (NASDAQ:AFMD), hence its stake in the company currently consists of 3.38 million common shares (which include 326,650 shares that can be obtained upon the Carve-Out Agreement), representing 10.15% of the float. Previously, the fund’s stake stood at 3.78 million shares, according to its 13F filing for the end of June.
Affimed N.V. is a clinical-stage biopharmaceutical company that works on producing cancer immunotherapies. Since the beginning of the year, the company’s stock has lost 60.39%. For the second quarter of 2016, Affimed N.V. disclosed a loss per share of €0.24 ($0.27) missing the estimates of a loss per share of €0.20, and revenue of €2.1 million, topping the estimates of €1.9 million.
Among investors from our database, nine reported long positions in Affimed N.V. (NASDAQ:AFMD) at the end of June, up by one from the previous quarter. Some of the bullish investors include Bain Capital’s Brookside Capital with a position valued at $5.20 million, James A. Silverman’s Opaleye Management which held a position worth around $1.48 million, Louis Bacon’s Moore Capital Management, and Julian and Felix Baker’s Baker Bros. Advisors.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| OrbiMed Advisors | 0 | 3,375,000 | 0 | 3,375,000 | 3,375,000 | 10.15% |
| OrbiMed Capital GP III | 0 | 3,343,965 | 0 | 3,343,965 | 3,343,965 | 10.05% |
| Samuel D. Isaly | 0 | 3,375,000 | 0 | 3,375,000 | 3,375,000 | 10.15% |
Page 1 of 12 – SEC Filing
AFFIMED N.V.
COMMON STOCK
N01045108
Telephone: (212) 739-6400
September 22, 2016
(Date of Event Which Requires Filing of this Statement)
DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks
If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.
Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Herc Holdings Inc (HRI): Billionaire Mario Gabelli’s GAMCO Investors...
Five Stocks That Will Benefit If Donald Trump Wins Presidency
Skypeople Fruit Juice Inc. (SPU), Lands’ End Inc. (LE) & Others: Why...
InterContinental Hotels (IHG), First NBC Bank (FNBC) & More: Afternoon...
GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why...
Five Stocks That Will Benefit If Hillary Clinton Wins Presidential Election
